男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Latest

Pharmaceutical companies sign deals with China's tech giants

By Zhou Wenting in Shanghai | chinadaily.com.cn | Updated: 2020-11-08 16:52
Share
Share - WeChat
Servier China and Alibaba Health sign a strategic cooperation agreement during the ongoing 3rd China International Import Expo, on on Nov 7, 2020. [Photo provided to China Daily]

Participating multinational pharmaceutical companies at the ongoing 3rd China International Import Expo have lined up to sign collaboration agreements with domestic digital health giants as part of their efforts to ride the wave of the country's smart medical development.

On Saturday, Novartis Oncology, Servier China and Pfizer signed their collaboration agreement with Alibaba Health at the CIIE.

Some of these collaborations were designed to provide full-cycle digital healthcare solutions for patients with multiple types of chronic diseases throughout diagnosis, treatment and long-term disease management process, and some others were intended to create innovative models of getting vaccination.

On the same day, the United States-based Bristol-Myers Squibb also signed a collaboration agreement with JD Health to establish a comprehensive, technology-driven platform for liver disease patients, from getting early diagnosis to long-term disease management.

The strategic cooperation between Novartis Oncology and Alibaba Health is aimed to build an innovative digital healthcare model that combines the former's strength in precision medicine and the latter's in digital technology, providing patient-centric, one-stop services to cancer patients from online prescription, online drug purchase, medication compliance and payment, according to Novartis Oncology.

"With shared vision and goals, we hope our strategic partnership will enable more convenient access to high-quality medical services for cancer patients through digital solutions, thereby improving their quality of life and alleviating disease burden," Zhu Shunyan, chairman and CEO of Alibaba Health, said.

Servier China hopes to rely on the Alibaba Health Pharmacy Platform to carry out online education about chronic diseases to improve awareness of disease and standard treatment, and to rely on the Alibaba Health Online Hospital for follow-up medical services through the internet.

The company said that within the coming three years, both sides will continue to optimize processes and replicate online education and treatment programs in chronic diseases to more disease areas.

The partnership also may explore e-commercial models, including debuting a therapy through the internet, to deliver medical products to a wider range of patients.

Pfizer's cooperation with Alibaba Health focuses on building complete and full-chain vaccination service online. Availing of the latter's platforms, Pfizer will carry out publicize information about vaccines and try to promote the realization of online closed-loop service. This includes education, consultation and making an appointment, Pfizer's representative said.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 墨竹工卡县| 连州市| 渭南市| 南丰县| 新巴尔虎左旗| 元阳县| 彰化市| 安西县| 十堰市| 凤台县| 奉节县| 左贡县| 维西| 汾阳市| 安阳县| 仪陇县| 滕州市| 宁陵县| 荃湾区| 新营市| 祁阳县| 新竹市| 沾化县| 景德镇市| 淅川县| 商河县| 沧州市| 奎屯市| 聂拉木县| 上栗县| 习水县| 湘潭县| 梁平县| 扎兰屯市| 正定县| 庆阳市| 泰兴市| 涞源县| 香格里拉县| 渭南市| 霍州市|